Vitamin D and anemia: Insights into an emerging association

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 22, Issue 6, 2015, Pages 432-438

  Smith, Ellen M ^a   Tangpricha, Vin ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Anemia; Hepcidin; Inflammation; Vitamin D

Indexed keywords

CALCITRIOL; COLECALCIFEROL; ERYTHROPOIETIN; FIBROBLAST GROWTH FACTOR 23; HEMOGLOBIN; HEPCIDIN; MESSENGER RNA; PARATHYROID HORMONE; PARICALCITOL; VITAMIN D; ANTIINFLAMMATORY AGENT; FIBROBLAST GROWTH FACTOR;

ANEMIA; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL PRACTICE; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; ETHNIC DIFFERENCE; HEMOGLOBIN DETERMINATION; HEMOGLOBIN SYNTHESIS; HUMAN; INFLAMMATION; IRON ABSORPTION; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON METABOLISM; IRON STORAGE; NONHUMAN; PROMOTER REGION; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; VITAMIN D DEFICIENCY; VITAMIN D RESPONSIVE ELEMENT; BLOOD; CLINICAL TRIAL (TOPIC); COMPLICATION; DRUG EFFECTS; PHYSIOLOGY;

ANEMIA; ANTI-INFLAMMATORY AGENTS; CLINICAL TRIALS AS TOPIC; ERYTHROPOIESIS; FIBROBLAST GROWTH FACTORS; HUMANS; PARATHYROID HORMONE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84947032280     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0000000000000199     Document Type: Review

References (45)

1. Sim JJ, Lac PT, Liu IL, et al. Vitamin D deficiency and anemia: a cross-sectional study. Ann Hematol 2010;89:447-452.
2. Perlstein TS, Pande R, Berliner N, Vanasse GJ. Prevalence of 25-hydroxyvitamin D deficiency in subgroups of elderly persons with anemia: association with anemia of inflammation. Blood 2011;117:2800-2806.
3. Patel NM, Gutierrez OM, Andress DL, et al. Vitamin D deficiency and anemia in early chronic kidney disease. Kidney Int 2010;77:715-720.
4. Coutard A, Garlantezec R, Estivin S, et al. Association of vitamin D deficiency and anemia in a hospitalized geriatric population: denutrition as a confounding factor. Ann Hematol 2013;92:615-619.
5. Jin HJ, Lee JH, Kim MK. The prevalence of vitamin D deficiency in iron-deficient and normal children under the age of 24 months. Blood Res 2013;48:40-45.
6. Shin JY, Shim JY. Low vitamin D levels increase anemia risk in Korean women. Clin Chim Acta 2013;421:177-180.
7. Zittermann A, Jungvogel A, Prokop S, et al. Vitamin D deficiency is an independent predictor of anemia in end-stage heart failure. Clin Res Cardiol 2011;100:781-788.
8. Bacchetta J, Chun RF, Gales B, et al. Antibacterial responses by peritoneal macrophages are enhanced following vitamin D supplementation. PLoS One 2014;9:e116530. This study shows that in vitro and in vivo supplementation with vitamin D suppresses hepcidin mRNA expression in peritoneal macrophages of patients with CKD undergoing peritoneal dialysis, indicating a potential regulatory role of vitamin D in iron homoeostasis and immunity, particularly in the setting of infection.
9. Bacchetta J, Zaritsky JJ, Sea JL, et al. Suppression of iron-regulatory hepcidin by vitamin D. J Am Soc Nephrol 2014;25:564-572. This study demonstrates a regulatory role for vitamin D in iron homeostasis by identifying VDREs on the HAMP gene, and showing that in vitro treatment of monocytes and hepacyotes with vitamin D supresses hepcidin mRNA transcription, and in vivo vitamin D supplementation of healthy humans reduces serum hepcidin concentrations.
10. Zughaier SM, Alvarez JA, Sloan JH, et al. The role of vitamin D in regulating the iron-hepcidin-ferroportin axis in monocytes. J Clin Transl Endocrinol 2014;1:19-25. This study shows that in vitro treatment with calcitriol reduces inflammatory cyokine release from monocytes, lowers hepcidin mRNA expression, and increases ferroportin mRNA expression, suggesting a regulatory role of vitamin D on the hepcidin-ferroportin axis.
11. Nemeth E, Ganz T. Anemia of inflammation. Hematol Oncol Clin North Am 2014;28:671-681. This review provides the reader with a comprehensive overview of anemia of inflammation.
12. Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res 2014;7:69-87.
13. Silva B, Faustino P. An overview of molecular basis of iron metabolism regulation and the associated pathologies. Biochim Biophys Acta 2015;1852:1347-1359.
14. Ruchala P, Nemeth E. The pathophysiology and pharmacology of hepcidin. Trends Pharmacol Sci 2014;35:155-161.
15. Nairz M, Haschka D, Demetz E, Weiss G. Iron at the interface of immunity and infection. Front Pharmacol 2014;5:152.
16. Poggiali E, Migone De Amicis M, Motta I. Anemia of chronic disease: a unique defect of iron recycling for many different chronic diseases. Eur J Intern Med 2014;25:12-17.
17. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-1023.
18. Alon DB, Chaimovitz C, Dvilansky A, et al. Novel role of 1, 25 (OH) 2D3 in induction of erythroid progenitor cell proliferation. Exp Hematol 2002;30:403-409.
19. Aucella F, Scalzulli RP, Gatta G, et al. Calcitriol increases burst-forming uniterythroid proliferation in chronic renal failure. A synergistic effect with r-HuEpo. Nephron Clin Pract 2003;95:c121-c127.
20. Refaat B, Ashour TH, El-Shemi AG. Ribavirin induced anaemia: the effect of vitamin D supplementation on erythropoietin and erythrocyte indices in normal Wistar rat. Int J Clin Exp Med 2014;7:2667-2676. This study examined the effect of vitamin D supplementation on erythrocyte indices in rats treated with pegylated interferon-a and ribavirin and found that vitamin D may protect against drug-induced disturbances in erythrocyte indices and erythropoietin.
21. Kiss Z, Ambrus C, Almasi C, et al. Serum 25 (OH)-cholecalciferol concentration is associated with hemoglobin level and erythropoietin resistance in patients on maintenance hemodialysis. Nephron Clin Pract 2011;117:c373-c378.
22. Kumar VA, Kujubu DA, Sim JJ, et al. Vitamin D supplementation and recombinant human erythropoietin utilization in vitamin D-deficient hemodialysis patients. J Nephrol 2011;24:98-105.
23. Rianthavorn P, Boonyapapong P. Ergocalciferol decreases erythropoietin resistance in children with chronic kidney disease stage 5. Pediatr Nephrol 2013;28:1261-1266.
24. Afsar B, Agca E, Turk S. Comparison of erythropoietin resistance in hemodialysis patients using calcitriol, cinacalcet or paricalcitol. J Clin Pharmacol 2015. [Epub ahead of print] This study was a cross-sectional analysis to examine the association of calcitriol, paricalcitol, and cinacalcet use with ESA resistance, and found that paricalcitol use was associated with lower ESA resistance, suggesting that treatment with paricalcitol may lower ESA requirements in hemodialysis patients.
25. Coe LM, Madathil SV, Casu C, et al. FGF-23 is a negative regulator of prenatal and postnatal erythropoiesis. J Biol Chem 2014;289:9795-9810. This study showed that in mice with genetic depletion of FGF-23 erythropoiesis was increased, and administration of FGF-23 to wild-type mice resulted in decreased erythropoiesis, suggesting a novel role for FGF-23 as a negative regulator of erythropoiesis and potential contributor to anemia.
26. Vadakke Madathil S, Coe LM, Casu C, Sitara D. Klotho deficiency disrupts hematopoietic stem cell development and erythropoiesis. Am J Pathol 2014;184:827-841. This study suggests that Klotho plays a regulatory role in hematopoiesis.
27. Scialla JJ, Xie H, Rahman M, et al. Fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol 2014;25:349-360.
28. Scialla JJ, Wolf M. Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. Nat Rev Nephrol 2014;10:268-278.
29. Icardi A, Paoletti E, De Nicola L, et al. Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation. Nephrol Dial Transplant 2013;28:1672-1679.
30. Russo, D. ,Morrone, L.,Di Iorio, B.,Andreucci, M.,De Gregorio, M.G.,Errichiello, C.,Russo, L.,Locatelli, F. "Parathyroid hormone may be an early predictor of low serum hemoglobin concentration in patients with not advanced stages of chronic kidney disease" in Journal of Nephrology ,Volume 28, Issue 6, 2015, Pages 701-708
31. Gillespie IA, Macdougall IC, Richards S, et al. Factors precipitating erythropoiesisstimulating agent responsiveness in a European haemodialysis cohort: case-crossover study. Pharmacoepidemiol Drug Saf 2015;24:414-426.
32. Ernst JB, Becker T, Kuhn J, et al. Independent association of circulating vitamin D metabolites with anemia risk in patients scheduled for cardiac surgery. PLoS One 2015;10:e0124751.
33. Hirani V, Cumming RG, Blyth F, et al. Cross-sectional and longitudinal associations between the active vitamin D metabolite (1, 25-dihydroxyvitamin D) and haemoglobin levels in older Australian men: the Concord Health and Ageing in Men Project. Age 2015;37:9749. This study indicates a positive association between calcitriol and hemoglobin concentrations both cross-sectionally and longitudinally.
34. Lee JA, Hwang JS, Hwang IT, et al. Low vitamin D levels are associated with both iron deficiency and anemia in children and adolescents. Pediat Hematol Oncol 2015;32:99-108.
35. Smith EM, Alvarez JA, Martin GS, et al. Vitamin D deficiency is associated with anaemia among African Americans in a US cohort. Br J Nutr 2015;113:1732-1740. This study further supports the association of vitamin D deficiency with increased odds of anemia and demonstrates that the association may be specific to anemia of inflammation and may differ between race groups.
36. Ganji V, Zhang X, Tangpricha V. Serum 25-hydroxyvitamin D concentrations and prevalence estimates of hypovitaminosis D in the U. S. population based on assay-adjusted data. J Nutr 2012;142:498-507.
37. Zakai NA, McClure LA, Prineas R, et al. Correlates of anemia in American blacks and whites: the REGARDS Renal Ancillary Study. Am J Epidemiol 2009;169:355-364.
38. Atkinson MA, Melamed ML, Kumar J, et al. Vitamin D, race, and risk for anemia in children. J Pediatr 2014;164:153-158; e151. This paper indicates that vitamin D deficiency is associated with anemia in a nationally representative sample of U. S. children and adolescents, but the association differed by race such that the 25 (OH) D threshold levels for reduced hemoglobin concentrations were lower in black children compared to white children.
39. Albitar S, Genin R, Fen-Chong M, et al. High-dose alfacalcidol improves anaemia in patients on haemodialysis. Nephrol Dial Transplant 1997;12:514-518.
40. Goicoechea M, Vazquez MI, Ruiz MA, et al. Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients. Nephron 1998;78:23-27.
41. Lin CL, Hung CC, Yang CT, Huang CC. Improved anemia and reduced erythropoietin need by medical or surgical intervention of secondary hyperparathyroidism in hemodialysis patients. Ren Fail 2004;26:289-295.
42. Riccio E, Sabbatini M, Bruzzese D, et al. Effect of paricalcitol vs calcitriol on hemoglobin levels in chronic kidney disease patients: a randomized trial. PLoS One 2015;10:e0118174. This study demonstrated that treatment with paricalcitol may significantly increase hemoglobin concentrations in patients with CKD and anemia, offering a potential alternative therapeutic approach for anemia in CKD.
43. Sooragonda B, Bhadada SK, Shah VN, et al. Effect of vitamin D replacement on hemoglobin concentration in subjects with concurrent iron-deficiency anemia and vitamin D deficiency: a randomized, single-blinded, placebocontrolled trial. Acta Haematol 2015;133:31-35.
44. Atkinson MA, Kim JY, Roy CN, et al. Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort. Pediatr Nephrol 2015;30:635-643.
45. Pasricha SR, Atkinson SH, Armitage AE, et al. Expression of the iron hormone hepcidin distinguishes different types of anemia in African children. Sci Transl Med 2014;6:235re233. This study showed that hepcidin concentrations could be used to distinguish between iron deficiency anemia and anemia of inflammation, offering a useful identifier for diagnosing and targeting treatment for anemia.